Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the treatment effect of intravenous TAK-954 in improving the average daily protein adequacy received through enteral nutrition in critically-ill participants dev...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Millennium Pharmaceuticals, Inc.
NCT07426003 · Enteral Nutrition's Effect on the Gut
NCT05993390 · Neuromuscular Blockade, Critical Illness, and more
NCT05218083 · COVID-19, Critical Illness, and more
NCT05673408 · Critical Illness
NCT07579728 · Critical Illness, Frailty, and more
Joseph M Still Burn Centers
Augusta, Georgia
Eastern Idaho Medical Consultants
Idaho Falls, Idaho
Illinois Lung & Critical Care Institute
Peoria, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions